APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gadolinium-Based Contrast Agents

Compare research editions
View pricing & licenses

Selected research

Industry Research

Gadolinium-Based Contrast Agents Industry Research Report 2026

31 December 2025128 pages

Choose your research edition.

Industry ResearchGadolinium-Based Contrast Agents Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Gadolinium-Based Contrast Agents Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Gadolinium-Based Contrast Agents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gadolinium-Based Contrast Agents Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Gadolinium-Based Contrast Agents Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Gadolinium-Based Contrast Agents market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Gadolinium-Based Contrast Agents is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Gadolinium-Based Contrast Agents is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Gadolinium-Based Contrast Agents is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Gadolinium-Based Contrast Agents include Agfa, BeiLu Pharma, Bracco Imaging, GE Healthcare, Guerbet Group, Hengrui Medicine, Lantheus, Marotrast and YRPG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Gadolinium-Based Contrast Agents market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Gadolinium-Based Contrast Agents Market by Company

Agfa

BeiLu Pharma

Bracco Imaging

GE Healthcare

Guerbet Group

Hengrui Medicine

Lantheus

Marotrast

YRPG

Bayer

Jiangsu Hengrui Medicine

Stary

Gadolinium-Based Contrast Agents Segment by Type

Linear Gadolinium-Based Contrast Agents

Macrocycle Gadolinium-Based Contrast Agents

Gadolinium-Based Contrast Agents Segment by Application

Hospital

Specialist Clinic

Others

Gadolinium-Based Contrast Agents Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gadolinium-Based Contrast Agents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gadolinium-Based Contrast Agents and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gadolinium-Based Contrast Agents.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Gadolinium-Based Contrast Agents manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Gadolinium-Based Contrast Agents by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Gadolinium-Based Contrast Agents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Gadolinium-Based Contrast Agents Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Gadolinium-Based Contrast Agents Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Gadolinium-Based Contrast Agents Sales Market Share by Manufacturers (2021-2026) Table 8. Global Gadolinium-Based Contrast Agents Revenue of Manufacturers (2021-2026) Table 9. Global Gadolinium-Based Contrast Agents Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Gadolinium-Based Contrast Agents Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Gadolinium-Based Contrast Agents Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Gadolinium-Based Contrast Agents, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Gadolinium-Based Contrast Agents, Product Type & Application Table 14. Global Gadolinium-Based Contrast Agents Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Gadolinium-Based Contrast Agents by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Agfa Company Information Table 19. Agfa Business Overview Table 20. Agfa Gadolinium-Based Contrast Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Agfa Gadolinium-Based Contrast Agents Product Portfolio Table 22. Agfa Recent Developments Table 23. BeiLu Pharma Company Information Table 24. BeiLu Pharma Business Overview Table 25. BeiLu Pharma Gadolinium-Based Contrast Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. BeiLu Pharma Gadolinium-Based Contrast Agents Product Portfolio Table 27. BeiLu Pharma Recent Developments Table 28. Bracco Imaging Company Information Table 29. Bracco Imaging Business Overview Table 30. Bracco Imaging Gadolinium-Based Contrast Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Bracco Imaging Gadolinium-Based Contrast Agents Product Portfolio Table 32. Bracco Imaging Recent Developments Table 33. GE Healthcare Company Information Table 34. GE Healthcare Business Overview Table 35. GE Healthcare Gadolinium-Based Contrast Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. GE Healthcare Gadolinium-Based Contrast Agents Product Portfolio Table 37. GE Healthcare Recent Developments Table 38. Guerbet Group Company Information Table 39. Guerbet Group Business Overview Table 40. Guerbet Group Gadolinium-Based Contrast Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Guerbet Group Gadolinium-Based Contrast Agents Product Portfolio Table 42. Guerbet Group Recent Developments Table 43. Hengrui Medicine Company Information Table 44. Hengrui Medicine Business Overview Table 45. Hengrui Medicine Gadolinium-Based Contrast Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Hengrui Medicine Gadolinium-Based Contrast Agents Product Portfolio Table 47. Hengrui Medicine Recent Developments Table 48. Lantheus Company Information Table 49. Lantheus Business Overview Table 50. Lantheus Gadolinium-Based Contrast Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Lantheus Gadolinium-Based Contrast Agents Product Portfolio Table 52. Lantheus Recent Developments Table 53. Marotrast Company Information Table 54. Marotrast Business Overview Table 55. Marotrast Gadolinium-Based Contrast Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Marotrast Gadolinium-Based Contrast Agents Product Portfolio Table 57. Marotrast Recent Developments Table 58. YRPG Company Information Table 59. YRPG Business Overview Table 60. YRPG Gadolinium-Based Contrast Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. YRPG Gadolinium-Based Contrast Agents Product Portfolio Table 62. YRPG Recent Developments Table 63. Bayer Company Information Table 64. Bayer Business Overview Table 65. Bayer Gadolinium-Based Contrast Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Bayer Gadolinium-Based Contrast Agents Product Portfolio Table 67. Bayer Recent Developments Table 68. Jiangsu Hengrui Medicine Company Information Table 69. Jiangsu Hengrui Medicine Business Overview Table 70. Jiangsu Hengrui Medicine Gadolinium-Based Contrast Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Jiangsu Hengrui Medicine Gadolinium-Based Contrast Agents Product Portfolio Table 72. Jiangsu Hengrui Medicine Recent Developments Table 73. Stary Company Information Table 74. Stary Business Overview Table 75. Stary Gadolinium-Based Contrast Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Stary Gadolinium-Based Contrast Agents Product Portfolio Table 77. Stary Recent Developments Table 78. Global Gadolinium-Based Contrast Agents Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 79. Global Gadolinium-Based Contrast Agents Sales by Region (2021-2026) & (K Units) Table 80. Global Gadolinium-Based Contrast Agents Sales Market Share by Region (2021-2026) Table 81. Global Gadolinium-Based Contrast Agents Sales by Region (2027-2032) & (K Units) Table 82. Global Gadolinium-Based Contrast Agents Sales Market Share by Region (2027-2032) Table 83. Global Gadolinium-Based Contrast Agents Revenue by Region (2021-2026) & (US$ Million) Table 84. Global Gadolinium-Based Contrast Agents Revenue Market Share by Region (2021-2026) Table 85. Global Gadolinium-Based Contrast Agents Revenue by Region (2027-2032) & (US$ Million) Table 86. Global Gadolinium-Based Contrast Agents Revenue Market Share by Region (2027-2032) Table 87. North America Gadolinium-Based Contrast Agents Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 88. North America Gadolinium-Based Contrast Agents Sales by Country (2021-2026) & (K Units) Table 89. North America Gadolinium-Based Contrast Agents Sales by Country (2027-2032) & (K Units) Table 90. North America Gadolinium-Based Contrast Agents Revenue by Country (2021-2026) & (US$ Million) Table 91. North America Gadolinium-Based Contrast Agents Revenue by Country (2027-2032) & (US$ Million) Table 92. Europe Gadolinium-Based Contrast Agents Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 93. Europe Gadolinium-Based Contrast Agents Sales by Country (2021-2026) & (K Units) Table 94. Europe Gadolinium-Based Contrast Agents Sales by Country (2027-2032) & (K Units) Table 95. Europe Gadolinium-Based Contrast Agents Revenue by Country (2021-2026) & (US$ Million) Table 96. Europe Gadolinium-Based Contrast Agents Revenue by Country (2027-2032) & (US$ Million) Table 97. Asia Pacific Gadolinium-Based Contrast Agents Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. Asia Pacific Gadolinium-Based Contrast Agents Sales by Country (2021-2026) & (K Units) Table 99. Asia Pacific Gadolinium-Based Contrast Agents Sales by Country (2027-2032) & (K Units) Table 100. Asia Pacific Gadolinium-Based Contrast Agents Revenue by Country (2021-2026) & (US$ Million) Table 101. Asia Pacific Gadolinium-Based Contrast Agents Revenue by Country (2027-2032) & (US$ Million) Table 102. South America Gadolinium-Based Contrast Agents Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. South America Gadolinium-Based Contrast Agents Sales by Country (2021-2026) & (K Units) Table 104. South America Gadolinium-Based Contrast Agents Sales by Country (2027-2032) & (K Units) Table 105. South America Gadolinium-Based Contrast Agents Revenue by Country (2021-2026) & (US$ Million) Table 106. South America Gadolinium-Based Contrast Agents Revenue by Country (2027-2032) & (US$ Million) Table 107. Middle East and Africa Gadolinium-Based Contrast Agents Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. Middle East and Africa Gadolinium-Based Contrast Agents Sales by Country (2021-2026) & (K Units) Table 109. Middle East and Africa Gadolinium-Based Contrast Agents Sales by Country (2027-2032) & (K Units) Table 110. Middle East and Africa Gadolinium-Based Contrast Agents Revenue by Country (2021-2026) & (US$ Million) Table 111. Middle East and Africa Gadolinium-Based Contrast Agents Revenue by Country (2027-2032) & (US$ Million) Table 112. Global Gadolinium-Based Contrast Agents Sales by Type (2021-2026) & (K Units) Table 113. Global Gadolinium-Based Contrast Agents Sales by Type (2027-2032) & (K Units) Table 114. Global Gadolinium-Based Contrast Agents Sales Market Share by Type (2021-2026) Table 115. Global Gadolinium-Based Contrast Agents Sales Market Share by Type (2027-2032) Table 116. Global Gadolinium-Based Contrast Agents Revenue by Type (2021-2026) & (US$ Million) Table 117. Global Gadolinium-Based Contrast Agents Revenue by Type (2027-2032) & (US$ Million) Table 118. Global Gadolinium-Based Contrast Agents Revenue Market Share by Type (2021-2026) Table 119. Global Gadolinium-Based Contrast Agents Revenue Market Share by Type (2027-2032) Table 120. Global Gadolinium-Based Contrast Agents Price by Type (2021-2026) & (US$/Unit) Table 121. Global Gadolinium-Based Contrast Agents Price by Type (2027-2032) & (US$/Unit) Table 122. Global Gadolinium-Based Contrast Agents Sales by Application (2021-2026) & (K Units) Table 123. Global Gadolinium-Based Contrast Agents Sales by Application (2027-2032) & (K Units) Table 124. Global Gadolinium-Based Contrast Agents Sales Market Share by Application (2021-2026) Table 125. Global Gadolinium-Based Contrast Agents Sales Market Share by Application (2027-2032) Table 126. Global Gadolinium-Based Contrast Agents Revenue by Application (2021-2026) & (US$ Million) Table 127. Global Gadolinium-Based Contrast Agents Revenue by Application (2027-2032) & (US$ Million) Table 128. Global Gadolinium-Based Contrast Agents Revenue Market Share by Application (2021-2026) Table 129. Global Gadolinium-Based Contrast Agents Revenue Market Share by Application (2027-2032) Table 130. Global Gadolinium-Based Contrast Agents Price by Application (2021-2026) & (US$/Unit) Table 131. Global Gadolinium-Based Contrast Agents Price by Application (2027-2032) & (US$/Unit) Table 132. Key Raw Materials Table 133. Raw Materials Key Suppliers Table 134. Gadolinium-Based Contrast Agents Distributors List Table 135. Gadolinium-Based Contrast Agents Customers List Table 136. Gadolinium-Based Contrast Agents Industry Trends Table 137. Gadolinium-Based Contrast Agents Industry Drivers Table 138. Gadolinium-Based Contrast Agents Industry Restraints Table 139. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Gadolinium-Based Contrast Agents Product Image Figure 5. Global Gadolinium-Based Contrast Agents Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Gadolinium-Based Contrast Agents Market Size (2021-2032) & (US$ Million) Figure 7. Global Gadolinium-Based Contrast Agents Sales (2021-2032) & (K Units) Figure 8. Global Gadolinium-Based Contrast Agents Average Price (US$/Unit) & (2021-2032) Figure 9. Linear Gadolinium-Based Contrast Agents Product Image Figure 10. Macrocycle Gadolinium-Based Contrast Agents Product Image Figure 11. Hospital Product Image Figure 12. Specialist Clinic Product Image Figure 13. Others Product Image Figure 14. Global Gadolinium-Based Contrast Agents Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of Gadolinium-Based Contrast Agents, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 Gadolinium-Based Contrast Agents Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Gadolinium-Based Contrast Agents Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global Gadolinium-Based Contrast Agents Sales by Region in 2025 Figure 20. Global Gadolinium-Based Contrast Agents Revenue by Region in 2025 Figure 21. North America Gadolinium-Based Contrast Agents Market Size by Country in 2025 Figure 22. North America Gadolinium-Based Contrast Agents Sales Market Share by Country (2021-2032) Figure 23. North America Gadolinium-Based Contrast Agents Revenue Market Share by Country (2021-2032) Figure 24. United States Gadolinium-Based Contrast Agents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada Gadolinium-Based Contrast Agents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Europe Gadolinium-Based Contrast Agents Market Size by Country in 2025 Figure 27. Europe Gadolinium-Based Contrast Agents Sales Market Share by Country (2021-2032) Figure 28. Europe Gadolinium-Based Contrast Agents Revenue Market Share by Country (2021-2032) Figure 29. Germany Gadolinium-Based Contrast Agents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. France Gadolinium-Based Contrast Agents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. U.K. Gadolinium-Based Contrast Agents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. Italy Gadolinium-Based Contrast Agents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Netherlands Gadolinium-Based Contrast Agents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Asia Pacific Gadolinium-Based Contrast Agents Market Size by Country in 2025 Figure 35. Asia Pacific Gadolinium-Based Contrast Agents Sales Market Share by Country (2021-2032) Figure 36. Asia Pacific Gadolinium-Based Contrast Agents Revenue Market Share by Country (2021-2032) Figure 37. China Gadolinium-Based Contrast Agents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Japan Gadolinium-Based Contrast Agents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. South Korea Gadolinium-Based Contrast Agents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. India Gadolinium-Based Contrast Agents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Australia Gadolinium-Based Contrast Agents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. China Taiwan Gadolinium-Based Contrast Agents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Southeast Asia Gadolinium-Based Contrast Agents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Southeast Asia Gadolinium-Based Contrast Agents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South America Gadolinium-Based Contrast Agents Market Size by Country in 2025 Figure 46. South America Gadolinium-Based Contrast Agents Sales Market Share by Country (2021-2032) Figure 47. South America Gadolinium-Based Contrast Agents Revenue Market Share by Country (2021-2032) Figure 48. Mexico Gadolinium-Based Contrast Agents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Brazil Gadolinium-Based Contrast Agents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Argentina Gadolinium-Based Contrast Agents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Middle East and Africa Gadolinium-Based Contrast Agents Market Size by Country in 2025 Figure 52. Middle East and Africa Gadolinium-Based Contrast Agents Sales Market Share by Country (2021-2032) Figure 53. Middle East and Africa Gadolinium-Based Contrast Agents Revenue Market Share by Country (2021-2032) Figure 54. Turkey Gadolinium-Based Contrast Agents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Saudi Arabia Gadolinium-Based Contrast Agents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. UAE Gadolinium-Based Contrast Agents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Global Gadolinium-Based Contrast Agents Sales Market Share by Type (2021-2032) Figure 58. Global Gadolinium-Based Contrast Agents Revenue Market Share by Type (2021-2032) Figure 59. Global Gadolinium-Based Contrast Agents Price (US$/Unit) by Type (2021-2032) Figure 60. Global Gadolinium-Based Contrast Agents Sales Market Share by Application (2021-2032) Figure 61. Global Gadolinium-Based Contrast Agents Revenue Market Share by Application (2021-2032) Figure 62. Global Gadolinium-Based Contrast Agents Price (US$/Unit) by Application (2021-2032) Figure 63. Gadolinium-Based Contrast Agents Value Chain Figure 64. Gadolinium-Based Contrast Agents Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Gadolinium-Based Contrast Agents Industry Opportunities and Challenges

Scope & coverage.

Types
  • Linear Gadolinium-Based Contrast Agents
  • Macrocycle Gadolinium-Based Contrast Agents
Applications
  • Hospital
  • Specialist Clinic
  • Others
Companies covered
  • Agfa
  • BeiLu Pharma
  • Bracco Imaging
  • GE Healthcare
  • Guerbet Group
  • Hengrui Medicine
  • Lantheus
  • Marotrast
  • YRPG
  • Bayer
  • Jiangsu Hengrui Medicine
  • Stary

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Gadolinium-Based Contrast Agents Market Size (2021-2032)
  4. 2.2.2 Global Gadolinium-Based Contrast Agents Sales (2021-2032)
  5. 2.2.3 Global Gadolinium-Based Contrast Agents Market Average Price (2021-2032)
  6. 2.3 Gadolinium-Based Contrast Agents by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Linear Gadolinium-Based Contrast Agents
  9. 2.3.3 Macrocycle Gadolinium-Based Contrast Agents
  10. 2.4 Gadolinium-Based Contrast Agents by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Hospital
  13. 2.4.3 Specialist Clinic
  14. 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Gadolinium-Based Contrast Agents Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Gadolinium-Based Contrast Agents Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Gadolinium-Based Contrast Agents Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Gadolinium-Based Contrast Agents Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Gadolinium-Based Contrast Agents Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Gadolinium-Based Contrast Agents, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Gadolinium-Based Contrast Agents, Product Type & Application
  8. 3.8 Global Manufacturers of Gadolinium-Based Contrast Agents, Established Date
  9. 3.9 Global Gadolinium-Based Contrast Agents Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Agfa
  2. 4.1.1 Agfa Company Information
  3. 4.1.2 Agfa Business Overview
  4. 4.1.3 Agfa Gadolinium-Based Contrast Agents Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Agfa Gadolinium-Based Contrast Agents Product Portfolio
  6. 4.1.5 Agfa Recent Developments
  7. 4.2 BeiLu Pharma
  8. 4.2.1 BeiLu Pharma Company Information
  9. 4.2.2 BeiLu Pharma Business Overview
  10. 4.2.3 BeiLu Pharma Gadolinium-Based Contrast Agents Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 BeiLu Pharma Gadolinium-Based Contrast Agents Product Portfolio
  12. 4.2.5 BeiLu Pharma Recent Developments
  13. 4.3 Bracco Imaging
  14. 4.3.1 Bracco Imaging Company Information
  15. 4.3.2 Bracco Imaging Business Overview
  16. 4.3.3 Bracco Imaging Gadolinium-Based Contrast Agents Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Bracco Imaging Gadolinium-Based Contrast Agents Product Portfolio
  18. 4.3.5 Bracco Imaging Recent Developments
  19. 4.4 GE Healthcare
  20. 4.4.1 GE Healthcare Company Information
  21. 4.4.2 GE Healthcare Business Overview
  22. 4.4.3 GE Healthcare Gadolinium-Based Contrast Agents Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 GE Healthcare Gadolinium-Based Contrast Agents Product Portfolio
  24. 4.4.5 GE Healthcare Recent Developments
  25. 4.5 Guerbet Group
  26. 4.5.1 Guerbet Group Company Information
  27. 4.5.2 Guerbet Group Business Overview
  28. 4.5.3 Guerbet Group Gadolinium-Based Contrast Agents Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Guerbet Group Gadolinium-Based Contrast Agents Product Portfolio
  30. 4.5.5 Guerbet Group Recent Developments
  31. 4.6 Hengrui Medicine
  32. 4.6.1 Hengrui Medicine Company Information
  33. 4.6.2 Hengrui Medicine Business Overview
  34. 4.6.3 Hengrui Medicine Gadolinium-Based Contrast Agents Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Hengrui Medicine Gadolinium-Based Contrast Agents Product Portfolio
  36. 4.6.5 Hengrui Medicine Recent Developments
  37. 4.7 Lantheus
  38. 4.7.1 Lantheus Company Information
  39. 4.7.2 Lantheus Business Overview
  40. 4.7.3 Lantheus Gadolinium-Based Contrast Agents Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Lantheus Gadolinium-Based Contrast Agents Product Portfolio
  42. 4.7.5 Lantheus Recent Developments
  43. 4.8 Marotrast
  44. 4.8.1 Marotrast Company Information
  45. 4.8.2 Marotrast Business Overview
  46. 4.8.3 Marotrast Gadolinium-Based Contrast Agents Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Marotrast Gadolinium-Based Contrast Agents Product Portfolio
  48. 4.8.5 Marotrast Recent Developments
  49. 4.9 YRPG
  50. 4.9.1 YRPG Company Information
  51. 4.9.2 YRPG Business Overview
  52. 4.9.3 YRPG Gadolinium-Based Contrast Agents Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 YRPG Gadolinium-Based Contrast Agents Product Portfolio
  54. 4.9.5 YRPG Recent Developments
  55. 4.10 Bayer
  56. 4.10.1 Bayer Company Information
  57. 4.10.2 Bayer Business Overview
  58. 4.10.3 Bayer Gadolinium-Based Contrast Agents Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Bayer Gadolinium-Based Contrast Agents Product Portfolio
  60. 4.10.5 Bayer Recent Developments
  61. 4.11 Jiangsu Hengrui Medicine
  62. 4.11.1 Jiangsu Hengrui Medicine Company Information
  63. 4.11.2 Jiangsu Hengrui Medicine Business Overview
  64. 4.11.3 Jiangsu Hengrui Medicine Gadolinium-Based Contrast Agents Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Jiangsu Hengrui Medicine Gadolinium-Based Contrast Agents Product Portfolio
  66. 4.11.5 Jiangsu Hengrui Medicine Recent Developments
  67. 4.12 Stary
  68. 4.12.1 Stary Company Information
  69. 4.12.2 Stary Business Overview
  70. 4.12.3 Stary Gadolinium-Based Contrast Agents Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Stary Gadolinium-Based Contrast Agents Product Portfolio
  72. 4.12.5 Stary Recent Developments
5 Global Gadolinium-Based Contrast Agents Market Scenario by Region
  1. 5.1 Global Gadolinium-Based Contrast Agents Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Gadolinium-Based Contrast Agents Sales by Region: 2021-2032
  3. 5.2.1 Global Gadolinium-Based Contrast Agents Sales by Region: 2021-2026
  4. 5.2.2 Global Gadolinium-Based Contrast Agents Sales by Region: 2027-2032
  5. 5.3 Global Gadolinium-Based Contrast Agents Revenue by Region: 2021-2032
  6. 5.3.1 Global Gadolinium-Based Contrast Agents Revenue by Region: 2021-2026
  7. 5.3.2 Global Gadolinium-Based Contrast Agents Revenue by Region: 2027-2032
  8. 5.4 North America Gadolinium-Based Contrast Agents Market Facts & Figures by Country
  9. 5.4.1 North America Gadolinium-Based Contrast Agents Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Gadolinium-Based Contrast Agents Sales by Country (2021-2032)
  11. 5.4.3 North America Gadolinium-Based Contrast Agents Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Gadolinium-Based Contrast Agents Market Facts & Figures by Country
  15. 5.5.1 Europe Gadolinium-Based Contrast Agents Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Gadolinium-Based Contrast Agents Sales by Country (2021-2032)
  17. 5.5.3 Europe Gadolinium-Based Contrast Agents Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.6 Asia Pacific Gadolinium-Based Contrast Agents Market Facts & Figures by Country
  24. 5.6.1 Asia Pacific Gadolinium-Based Contrast Agents Market Size by Country: 2021 VS 2025 VS 2032
  25. 5.6.2 Asia Pacific Gadolinium-Based Contrast Agents Sales by Country (2021-2032)
  26. 5.6.3 Asia Pacific Gadolinium-Based Contrast Agents Revenue by Country (2021-2032)
  27. 5.6.4 China
  28. 5.6.5 Japan
  29. 5.6.6 South Korea
  30. 5.6.7 India
  31. 5.6.8 Australia
  32. 5.6.9 China Taiwan
  33. 5.6.10 Southeast Asia
  34. 5.7 South America Gadolinium-Based Contrast Agents Market Facts & Figures by Country
  35. 5.7.1 South America Gadolinium-Based Contrast Agents Market Size by Country: 2021 VS 2025 VS 2032
  36. 5.7.2 South America Gadolinium-Based Contrast Agents Sales by Country (2021-2032)
  37. 5.7.3 South America Gadolinium-Based Contrast Agents Revenue by Country (2021-2032)
  38. 5.7.4 Mexico
  39. 5.7.5 Brazil
  40. 5.7.6 Argentina
  41. 5.8 Middle East and Africa Gadolinium-Based Contrast Agents Market Facts & Figures by Country
  42. 5.8.1 Middle East and Africa Gadolinium-Based Contrast Agents Market Size by Country: 2021 VS 2025 VS 2032
  43. 5.8.2 Middle East and Africa Gadolinium-Based Contrast Agents Sales by Country (2021-2032)
  44. 5.8.3 Middle East and Africa Gadolinium-Based Contrast Agents Revenue by Country (2021-2032)
  45. 5.8.4 Turkey
  46. 5.8.5 Saudi Arabia
  47. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Gadolinium-Based Contrast Agents Sales by Type (2021-2032)
  2. 6.1.1 Global Gadolinium-Based Contrast Agents Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Gadolinium-Based Contrast Agents Sales Market Share by Type (2021-2032)
  4. 6.2 Global Gadolinium-Based Contrast Agents Revenue by Type (2021-2032)
  5. 6.2.1 Global Gadolinium-Based Contrast Agents Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Gadolinium-Based Contrast Agents Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Gadolinium-Based Contrast Agents Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Gadolinium-Based Contrast Agents Sales by Application (2021-2032)
  2. 7.1.1 Global Gadolinium-Based Contrast Agents Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Gadolinium-Based Contrast Agents Sales Market Share by Application (2021-2032)
  4. 7.2 Global Gadolinium-Based Contrast Agents Revenue by Application (2021-2032)
  5. 7.2.1 Global Gadolinium-Based Contrast Agents Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Gadolinium-Based Contrast Agents Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Gadolinium-Based Contrast Agents Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Gadolinium-Based Contrast Agents Value Chain Analysis
  2. 8.1.1 Gadolinium-Based Contrast Agents Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Gadolinium-Based Contrast Agents Production Mode & Process
  5. 8.2 Gadolinium-Based Contrast Agents Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Gadolinium-Based Contrast Agents Distributors
  8. 8.2.3 Gadolinium-Based Contrast Agents Customers
9 Global Gadolinium-Based Contrast Agents Analyzing Market Dynamics
  1. 9.1 Gadolinium-Based Contrast Agents Industry Trends
  2. 9.2 Gadolinium-Based Contrast Agents Industry Drivers
  3. 9.3 Gadolinium-Based Contrast Agents Industry Opportunities and Challenges
  4. 9.4 Gadolinium-Based Contrast Agents Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst